Rapid in situ carbon-13 hyperpolarization and imaging of acetate and pyruvate esters without external polarizer.

阅读:3
作者:Mohiuddin Obaid, de Maissin Henri, Pravdivtsev Andrey N, Brahms Arne, Herzog Marvin, Schröder Leif, Chekmenev Eduard Y, Herges Rainer, Hövener Jan-Bernd, Zaitsev Maxim, von Elverfeldt Dominik, Schmidt Andreas B
Hyperpolarized (13)C MRI visualizes real-time metabolic processes in vivo. In this study, we achieved high (13)C polarization in situ in the bore of an MRI system for precursor molecules of most widely employed hyperpolarized agents: [1-(13)C]acetate and [1-(13)C]pyruvate ethyl esters in their perdeuterated forms, enhancing hyperpolarization lifetimes, hyperpolarized to P(13C) ≈ 28% at 80 mM concentration and P(13C) ≈ 19% at 10 mM concentration, respectively. Using vinyl esters as unsaturated Parahydrogen-Induced Polarization via Side-Arm Hydrogenation (PHIP-SAH) precursors and our novel polarization setup, we achieved these hyperpolarization levels by fast side-arm hydrogenation in acetone-d(6) at elevated temperatures (up to 90°C) and hydrogenation pressures (up to 32 bar). We optimized the hyperpolarization process, reducing it to under 10 s, and employed advanced pulse sequences to enhance the polarization transfer efficiency. The hyperpolarization system has a small footprint, allowing it to be positioned in the same magnet, where (13)C MRI is performed. We exemplified the utility of the design with sub-second in situ (13)C MRI of ethyl [1-(13)C]pyruvate-d(6). However, challenges remain in side-arm cleavage and purification in the MRI system to extract highly polarized aqueous agent solutions. Our results showcase efficient and rapid (13)C hyperpolarization of these metabolite precursors in an MRI system with minimal additional hardware, promising to enhance future throughput and access to hyperpolarized (13)C MRI.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。